👀 #ICYMI : At #AUA24 , we talked with Yaw Nyame of Fred Hutchinson Cancer Center about the “high-risk” population in #ProstateCancer as well as how different natural history affects screening results and implications for early detection.

📺 Watch Now: buff.ly/3QNsGwg

Does #vitamin supplementation prevent #prostate #cancer or help in its treatment?

In our BJU International systematic review, Omid Yazdanpanah and I find the answer to this common clinical question is 'no' based off RCTs from the past 30 years.

Link: onlinelibrary.wiley.com/share/author/C…

💡 A study from Andrea Necchi and colleagues analyzed cohort B of the phase 2 #KEYNOTE057 trial in which patients with #BCG -unresponsive high-risk #NMIBC and papillary tumors without #CIS received #pembrolizumab #monotherapy .

📚 Read More: buff.ly/3WNQ4h5

👉 Stay tuned for the Oncology Brothers' Advancements in Oncology event at #ASCO24 , featuring Margaret Gatti-Mays MD MPH FACP, Dr. Cathy Eng, Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation, and Karine Tawagi MD!

🔬 #ICYMI : We spoke with Gulam Abbas Manji of Columbia Medicine on a new trial examining #gemcitabine with CXCR4 and anti-PD-1 inhibitors for pancreatic ductal adenocarcinoma.

📺 Learn how the combination has shown preliminary efficacy in mice: buff.ly/3UPjB8Z

#pancreaticcancer

👀 Don't miss our #AUA24 roundtable on risk stratification and treatment options for low-grade #UTUC with KATIE MURRAY, Scot Niglio MD, Alice Yu, Hong Truong, and Adam Feldman.

📺 Watch Now: buff.ly/4bmlmzZ

THIS is the definition of tenacity!

Congratulations to the brilliant Laura Bukavina & her team for continuing to lead the way in gut microbiome research in bladder cancer!

Much more to learn about the role of the gut microbiome in cancer pathogenesis & anti-tumor response as

🧠 A study from Wenxin (Vincent) Xu and colleagues sought to determine if #pKIM1 can serve as a risk stratification tool for patients with #renal masses by analyzing the relationship between #pKIM1 , surgical pathology, and clinical outcomes.

📚 Read More: buff.ly/3K3hCY9

Don't forget to watch our website for more coverage of the NKF Spring Clinical Meetings. #nephrology #kidney #NKFSCM
buff.ly/3wEvcOy

Very happy to chat to Uromigos about The Lancet Commission on Prostate Cancer. The ICR Listen now! open.spotify.com/episode/4KTac6…

DocWire News is covering ESMO Breast Cancer 2024, taking place May 15-17 in Berlin, Germany. 📰 Stay tuned for insightful #breastcancer related data and insights! #ESMOBreast24

Excited to see our #TeamCLE comprehensive review on papillary RCC published in Kidney Cancer under the mentorship of Shilpa Gupta and with star PGY2 Charbel Hobeika, MD! Great to have a collaboration Case Comp Cancer Ctr UH/CWRU Hematology/Oncology Fellowship CCF Hematology Oncology Fellows

👉content.iospress.com/articles/kidne…

Great podcast with Nick James on the The Lancet Prostate Cancer Commision examining the many aspects of the challenges for #prostatecancer for the next generation.

spotifyanchor-web.app.link/e/oqmnTDGtCJb

📺 Don't miss our conversation with Philippe spiess of Moffitt Cancer Center, on the prevalence of #TERT expression in #PenileCancer patients as well as a statistically significant increase in #TROP2 #mRNA expression levels in #PSCC patients.

👉 Watch Now: buff.ly/4dFalvo

In Nature Reviews Urology, Omid Yazdanpanah and I highlight #cancer #disparities experienced by #gender #minorities . We also offer potential solutions for healthcare professionals and institutions to overcome barriers in cancer care.

Link (full text): rdcu.be/dHNbe

🎧 Catch this Uromigos episode (@tompowles1, Brian Rini, MD) on side effects in patients with #metastatic hormone-sensitive #ProstateCancer .

👉 Featuring: Christopher Sweeney, MBBS, Matthew A. Smith, ONCODOC, and Dr. Lisa Horvath

👂 Listen Now: buff.ly/4bVmLh9

🎙️ At #AUA24 , KATIE MURRAY of NYU Langone Urology spoke with Dr. Yair Lotan of UT Southwestern Medical Center about his recent multicenter study featuring #longitudinal follow-up of
#UGN101 for #UTUC .

👀 Watch Now: buff.ly/3K2HEL8

#ICYMI : A recent study found that #apalutamide plus #ADT may benefit patients with high-risk #localized #ProstateCancer .

🧠 Learn More: buff.ly/3Uwolii

🎥 Catch our recent video with Dr. Patrick Soon Shiong of ImmunityBio, Inc. on the groundbreaking data related to #nogapendekin #alfa #inbakicept ( #Anktiva ) for #NMIBC presented at #AUA24 .

📺 Watch Now: buff.ly/4alFPnt

FDA published PARPi results by biomarker. Largest to date — confirming prior data that ATM and CHEK2 have poor response. High number for BRCA, CDK12, PALB2 adds confidence for good ORR + PFS

ascopubs.org/doi/abs/10.120…